BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6434769)

  • 1. [Growth hormone releasing factor].
    Shizume K
    Nihon Rinsho; 1984 Jun; 42(6):1483-92. PubMed ID: 6434769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth hormone releasing hormone (GRH)--pathophysiology, clinical aspects, therapy].
    von Werder K
    Verh Dtsch Ges Inn Med; 1987; 93():386-94. PubMed ID: 3126613
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic and therapeutic aspects of growth-hormone releasing factor].
    von Werder K; Losa M; Müller OA
    Internist (Berl); 1985 May; 26(5):259-65. PubMed ID: 3924850
    [No Abstract]   [Full Text] [Related]  

  • 4. [The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].
    Lecornu M
    Arch Fr Pediatr; 1973; 30(6):595-608. PubMed ID: 4375947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies on pituitary growth hormone. II. On the serum level in normal subjects and patients with various disorders].
    Isobe I
    Naika Hokan; 1970 Sep; 17(9):253-69. PubMed ID: 5531456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth hormone releasing factor tolerance test].
    Takano K
    Nihon Rinsho; 1986 Mar; 44(3):532-8. PubMed ID: 3090307
    [No Abstract]   [Full Text] [Related]  

  • 7. [The arginine test in functional semeiology of the incretion of the somatotrophic hormone].
    Giordano G; Marugo M; Minuto F; Barreca T
    Folia Endocrinol; 1971; 24(3):247-67. PubMed ID: 5171726
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ethanol on serum concentrations of somatomedin C and the growth hormone (GH) secretion stimulated by the releasing hormone (GHRH).
    Välimäki M; Pelkonen R; Karonen SL; Ylikahri R
    Alcohol Alcohol Suppl; 1987; 1():557-9. PubMed ID: 3122774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
    Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
    Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different responses of blood amino acids and blood glucose to the administration of insulin to patients with acromegaly.
    Zimmermann-Telschow H; Wiegelmann W; Solbach HG; Zimmermann H
    Horm Metab Res; 1973 Nov; 5(6):474-5. PubMed ID: 4767005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Somatomedins and growth disorders].
    Job JC; Donnadieu M; Schimpff RM
    Rev Prat; 1979 Feb; 29(11):925-6, 929-30, 933-4. PubMed ID: 432489
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dwarfism due to deficiency of "thyrotropin-releasing-hormone" (TRH) and "growth-hormone-releasing-factor" (GRF)].
    Morgner KD; Stendel A; Beisenherz W; Herrmann J; Kley HK; Krüskemper HL; zur Mühlen A von ; Zeidler U
    Dtsch Med Wochenschr; 1973 Mar; 98(11):539-41. PubMed ID: 4632970
    [No Abstract]   [Full Text] [Related]  

  • 14. Human somatomedin. Determination, occurrence, biological activity and purification.
    Hall K
    Acta Endocrinol Suppl (Copenh); 1972; 163():1052. PubMed ID: 4538721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in endocrine function tests. Growth hormone-releasing factor test].
    Takano K; Shizume K
    Nihon Rinsho; 1987 Nov; 45(11):2514-24. PubMed ID: 3127614
    [No Abstract]   [Full Text] [Related]  

  • 16. Dwarfism with elevated levels of plasma growth hormone.
    Najjar SS; Khachadurian AK; Ilbawi MN; Blizzard RM
    N Engl J Med; 1971 Apr; 284(15):809-12. PubMed ID: 5549802
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal growth hormone and dwarfism.
    Abucham-Filho JZ; Czepielewski MA; Ribeiro SR; Jaber HE; Lengyel AM; Chacra AR; Vieira JG
    N Engl J Med; 1985 Jul; 313(4):268-9. PubMed ID: 4040212
    [No Abstract]   [Full Text] [Related]  

  • 18. [Somatomedin following administration of growth hormone in pituitary dwarfism].
    Marek J; Kopecký A; Schüllerová M; Schreiberová O
    Cesk Pediatr; 1978 Oct; 33(10):582-6. PubMed ID: 729059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of radioimmunological determination of the somatotropic hormone in a series of children with low body height for the diagnosis of pituitary dwarfism].
    Lostia O; Boscherini B; Finocchi G; Girotti F; Mancuso G; Sartori L; Rossi C
    Ann Ist Super Sanita; 1971; 7(2):440-4. PubMed ID: 5154668
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute and long term responses to hGH in children with idiopathic small-for-dates dwarfism.
    Grunt JA; Enriquez AR; Daughaday WH
    J Clin Endocrinol Metab; 1972 Jul; 35(1):157-68. PubMed ID: 5032510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.